NEOGENOMICS INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($5.7m)
($846k) +85.22%
$2.6m +412.06%
$8.0m +203.26%
$4.2m -47.89%
($8.3m) -300.07%
($144.2m) -1628.17%
($88.0m) +39.02%
($78.7m) +10.51%
($108.0m) -37.22%
Net Income (Loss) Available to Common Stockholders, Basic ($30.4m)
($11.4m) +62.52%
$6.1m +153.44%
$8.0m +31.50%
$4.2m -47.89%
($8.3m) -300.07%
($144.2m) -1628.17%
($88.0m) +39.02%
($78.7m) +10.51%
Depreciation and amortization $15.9m $15.6m $15.8m $20.3m $25.9m $30.2m $35.4m $37.5m $39.1m $36.1m $65.5m
Amortization of Debt Issuance Costs $3.5m $440k $542k $390k $165k $178k $182k $185k $189k $87k
Amortization of Intangible Assets $7.3m $7.0m $5.9m $9.9m $9.8m $23.2m $34.1m $35.1m $33.4m $31.8m
Deferred Income Tax Expense (Benefit) ($1.7m) ($2.6m) $1.5m ($4.3m) ($18.1m) ($6.8m) ($15.2m) ($9.5m) ($2.6m) ($3.1m)
Share-based Payment Arrangement, Noncash Expense $5.0m $6.4m $7.0m $10.0m $10.2m $22.5m $24.7m $24.6m $33.4m $41.3m $36.2m
Share-based Payment Arrangement, Expense $24.6m $33.4m $41.3m $36.2m
Goodwill and Intangible Asset Impairment $27.8m
Goodwill, Impairment Loss $0 $0 $3.5m $7.7m
Impairment of Intangible Assets (Excluding Goodwill) $11.4m
Impairment of Intangible Assets, Finite-lived $3.5m $253k $0
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $0 $0 $0 $0 $0 $0
Restructuring Costs and Asset Impairment Charges $6.7m
Other Nonoperating Income (Expense) ($265k) $14k ($4.6m) $11.9m ($499k) ($213k) $644k ($379k) $296k
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable $18.4m $24.2m ($209k) $17.3m $12.6m $4.7m $7.6m $11.5m $19.3m $6.2m ($22.7m)
Increase (Decrease) in Inventories $1.1m $1.4m ($734k) $5.8m $15.2m ($1.6m) $1.1m $454k $2.7m $1.5m $7.0m
Inventory Write-down $400k
Net Cash Provided by (Used in) Operating Activities $21.5m
$18.0m -16.02%
$44.8m +148.30%
$23.4m -47.82%
$1.5m -93.75%
($26.7m) -1930.34%
($66.0m) -146.95%
($2.0m) +97.04%
$7.0m +459.60%
$5.2m -25.53%
$22.0m +321.59%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $7.5m $13.7m $14.3m $20.0m $29.1m $64.1m $30.9m $28.8m $41.1m $27.0m ($29.4m)
Debt Securities, Available-for-sale, Realized Gain (Loss) $0 $0 $0
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale $5.4m $63.0m $116.9m $112.2m $53.9m $20.1m
Payments to Acquire Businesses, Net of Cash Acquired ($1.0m) $125.4m ($399k) $37.0m $419.4m $0 $0 $6.5m ($463k)
Net Cash Provided by (Used in) Investing Activities ($6.5m) ($13.7m) ($139.7m) ($19.6m) ($159.4m) ($632.4m) $517k $76.7m $12.9m ($12.3m) ($19.9m)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt ($1.1m) $0 ($1.0m) ($1.4m) $0 $0
Proceeds from Issuance of Common Stock $3.8m $2.6m $11.2m $20.3m $15.1m $12.6m $4.6m $4.6m $962k $1.2m
Net Cash Provided by (Used in) Financing Activities ($25.9m)
($4.1m) +84.17%
$92.0m +2345.64%
$159.5m +73.41%
$235.6m +47.74%
$725.3m +207.85%
$11.8m -98.37%
$4.6m -61.50%
$4.6m +2.02%
($200.3m) -4410.98%
($11.4m) +94.32%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $12.8m $9.8m $163.2m $77.6m $316.8m $263.2m $342.5m $367.0m $159.6m $145.5m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.8m $9.8m $173.0m $250.6m $316.8m $263.2m $342.5m $367.0m $159.6m $145.5m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.8m $9.8m $0 $0 $316.8m $263.2m $342.5m $367.0m $159.6m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $5.4m $5.2m $6.5m $4.8m $2.9m $3.1m $3.4m $3.4m $3.8m $1.7m
Income Taxes Paid, Net $290k $284k ($31k) $319k $246k $148k $180k $175k $207k $515k
Additional Financial Items
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $450k $606k $2.0m $0 $0 $31k
Equity Securities, FV-NI, Unrealized Gain (Loss) $4.0m
Gain (Loss) on Disposition of Assets $450k $606k ($2.9m) ($292k) $49k ($31k)
Gain (Loss) on Disposition of Business ($1.1m) $0 $0
General and Administrative Expense $75.8m $88.8m $84.8m $128.0m $143.8m $221.3m $243.4m $243.1m $259.7m $273.3m
Goodwill $147.0m $147.0m $197.9m $198.6m $211.1m $527.1m $522.8m $522.8m $522.8m $524.3m $7.7m
Income Tax Expense (Benefit) ($1.7m) ($2.6m) $1.2m ($4.4m) ($18.2m) ($6.7m) ($15.1m) ($9.1m) ($1.9m) ($2.2m)
Interest Expense Nonoperating $6.6m $3.8m
Investment Income, Interest $18.4m $9.1m
Operating Expenses $107.8m $118.0m $117.2m $183.8m $199.9m $305.8m $345.5m $352.3m $382.2m $430.2m
Operating Lease, Expense $0 $5.6m $6.2m $8.7m $9.8m $9.2m $8.9m $6.8m
Proceeds from Stock Options Exercised $2.2m $8.6m $12.4m $18.4m $13.7m $10.3m $3.0m $3.6m $300k
Revenue from Contract with Customer, Including Assessed Tax $276.7m $408.8m $444.4m $484.3m $509.7m $591.6m $660.6m $727.3m